Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: Systematic review

References

• Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: The definition and classification of cerebral palsy April 2006. Developmental Medicine and Child Neurology Suppl 2007;109:8–14
   PubMedGoogle Scholar
• Tammik K, Matlep M, Ereline J, Gapeyeva H, Paasuke M. Muscle contractile properties in children with spastic diplegia. Brain & Development 2007;29:553–558
   Google Scholar
• Verschuren O, Ada L, Maltais DB, Gorter JW, Scianni A, Ketelaar M. Muscle strengthening in children and adolescents with spastic cerebral palsy: Considerations for future resistance training protocols. Physical Therapy 2011;91:1130–1139
   PubMed Web of Science ®Google Scholar
• Burtner PA, Woollacott MH, Craft GL, Roncesvalles MN. The capacity to adapt to changing balance threats: A comparison of children with cerebral palsy and typically developing children. Developmental Neurorehabilitation 2007;10:249–260
   PubMedGoogle Scholar
• Barela JA, Focks GM, Hilgeholt T, Barela AM, Carvalho Rde P, Savelsbergh GJ. Perception-action and adaptation in postural control of children and adolescents with cerebral palsy. Research in Developmental Disabilities 2011;32:2075–2083
   PubMed Web of Science ®Google Scholar
• Quinby JM, Abraham A. Musculoskeletal problems in cerebral palsy. Current Paediatrics 2005;15:9–14
   Google Scholar
• Drougia A, Giapros V, Krallis N, Theocharis P, Nikaki A, Tzoufi M, Andronikou S. Incidence and risk factors for cerebral palsy in infants with perinatal problems: A 15-year review. Early Human Developmental 2007;83:541–547
   PubMed Web of Science ®Google Scholar
• Kirby RS, Wingate MS, Van Naarden Braun K, Doernberg NS, Arneson CL, Benedict RE, Mulvihill B, Durkin MS, Fitzgerald RT, Maenner MJ, et al. Prevalence and functioning of children with cerebral palsy in four areas of the United States in 2006: A report from the Autism and Developmental Disabilities Monitoring Network. Research in Developmental Disabilities 2011;32:462–469
   PubMed Web of Science ®Google Scholar
• Crenna P. Spasticity and ‘spastic' gait in children with cerebral palsy. Neuroscience & Biobehavioral Reviews 1998;22:571–578
   Google Scholar
• Burke D, Wissel J, Donnan GA. Pathophysiology of spasticity in stroke. Neurology 2013;80:S20–S26
   PubMed Web of Science ®Google Scholar
• Nielsen JB, Petersen NT, Crone C, Sinkjaer T. Stretch reflex regulation in healthy subjects and patients with spasticity. Neuromodulation 2005;8:49–57
   PubMed Web of Science ®Google Scholar
• Nielsen JB, Crone C, Hultborn H. The spinal pathophysiology of spasticity – From a basic science point of view. Acta Physiologica (Oxford) 2007;189:171–180
   PubMed Web of Science ®Google Scholar
• Lieber RL, Steinman S, Barash IA, Chambers H. Structural and functional changes in spastic skeletal muscle. Muscle & Nerve 2004;29:615–627
   PubMed Web of Science ®Google Scholar
• Smith LR, Lee KS, Ward SR, Chambers HG, Lieber RL. Hamstring contractures in children with spastic cerebral palsy result from a stiffer extracellular matrix and increased in vivo sarcomere length. The Journal of Physiology 2011;589:2625–2639
   PubMed Web of Science ®Google Scholar
• Booth CM, Cortina-Borja MJ, Theologis TN. Collagen accumulation in muscles of children with cerebral palsy and correlation with severity of spasticity. Developmental Medicine and Child Neurology 2001;43:314–320
   PubMed Web of Science ®Google Scholar
• Woollacott MH, Shumway-Cook A. Postural dysfunction during standing and walking in children with cerebral palsy: What are the underlying problems and what new therapies might improve balance? Neural Plasticity 2005;12:211–219; discussion 263–272
   PubMedGoogle Scholar
• Damiano DL, Quinlivan J, Owen BF, Shaffrey M, Abel MF. Spasticity vs strength in cerebral palsy: Relationships among involuntary resistance, voluntary torque, and motor function. European Journal of Neurolology 2001;8:40–49
   PubMed Web of Science ®Google Scholar
• Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. Journal of Child Neurolology 2003;18:S50–S66
   PubMedGoogle Scholar
• Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y; Therapeutics, Technology Assessment Subcommittee of the American Academy of N. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1691–1698
   PubMed Web of Science ®Google Scholar
• Boyd RN, Pliatsios V, Starr R, Wolfe R, Graham HK. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Developmental Medicine and Child Neurology 2000;42:32–41
   PubMed Web of Science ®Google Scholar
• Friedman A, Diamond M, Johnston MV, Daffner C. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy. American Journal of Physical Medicine Rehabilitation 2000;79:53–59; quiz 75–76
   PubMed Web of Science ®Google Scholar
• Dodd SL, Selsby J, Payne A, Judge A, Dott C. Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle. Toxicon 2005;46:196–203
   Google Scholar
• Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). Journal of Biomechanics 2011;44:39–44
   PubMed Web of Science ®Google Scholar
• Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G, O'Flaherty S, Graham HK, Cerebral Palsy Institute. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: International consensus statement. European Journal of Neurolology 2010;17:9–37
   PubMed Web of Science ®Google Scholar
• Gough M, Shortland AP. Could muscle deformity in children with spastic cerebral palsy be related to an impairment of muscle growth and altered adaptation? Developmental Medicine & Child Neurology 2012;54:495–499
   PubMed Web of Science ®Google Scholar
• Thacker BE, Tomiya A, Hulst JB, Suzuki KP, Bremner SN, Gastwirt RF, Greaser ML, Lieber RL, Ward SR. Passive mechanical properties and related proteins change with botulinum neurotoxin A injection of normal skeletal muscle. Journal of Orthopaedic Research 2012;30:497–502
   Google Scholar
• Gracies JM. Physiological effects of botulinum toxin in spasticity. Movement Disorders 2004;19:S120–S128
   PubMed Web of Science ®Google Scholar
• Minamoto VB, Hulst JB, Lim M, Peace WJ, Bremner SN, Ward SR, Lieber RL. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation. Developmental Medicine and Child Neurology 2007;49:907–914
   Google Scholar
• dos Santos AN, Pavao SL, de Campos AC, Rocha NA. International Classification of Functioning, Disability and Health in children with cerebral palsy. Disability and Rehabilitation 2012;34:1053–1058
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009;339:b2700
   PubMed Web of Science ®Google Scholar
• Koman LA, Mooney JF, 3rd Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: Preliminary investigation. Journal of Pediatric Orthopedics 1993;13:489–495
   PubMed Web of Science ®Google Scholar
• Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology & Community Health 1998;52:377–384
   PubMed Web of Science ®Google Scholar
• Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ. Effectiveness of web-based interventions on patient empowerment: A systematic review and meta-analysis. Journal of Medical Internet Research 2010;12:e23
   PubMedGoogle Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174
   PubMed Web of Science ®Google Scholar
• Alhusaini AA, Crosbie J, Shepherd RB, Dean CM, Scheinberg A. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy. Developmental Medicine and Child Neurology 2011;53:553–558
   Google Scholar
• Sutherland DH, Kaufman KR, Wyatt MP, Chambers H. Injection of botulinurn A toxin into the gastrocnemius muscle of patients with cerebral palsy: A 3-dimensional motion analysis study. Gait & Posture 1996;4:269–279
   Google Scholar
• Speth LA, Leffers P, Janssen-Potten YJ, Vles JS. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: A randomized trial in children receiving intensive therapy. Developmental Medicine and Child Neurology 2005;47:468–473
   PubMed Web of Science ®Google Scholar
• Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC. Kinematic aiming task: Measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia. American Journal of Physical Medicine & Rehabilitation 2007;86:538–547
   Google Scholar
• Park ES, Park CI, Chang HC, Park CW, Lee DS. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy. Clinical Rehabilitation 2006;20:668–674
   PubMed Web of Science ®Google Scholar
• Wissel J, Muller J, Baldauf A, Ung SC, Ndayisaba J, Stockl B, Frischhut B, Haberfellner H, Poewe W. Gait analysis to assess the effects of botulinum toxin type A treatment in cerebral palsy: An openlabel study in 10 children with equinus gait pattern. European Journal of Neurology 1999;6:s63–s67
   Google Scholar
• Slawek J, Klimont L. Functional improvement in cerebral palsy patients treated with botulinum toxin A injections – Preliminary results. European Journal of Neurology 2003;10:313–317
   PubMed Web of Science ®Google Scholar
• Yang TF, Chan RC, Chuang TY, Liu TJ, Chiu JW. Treatment of cerebral palsy with botulinum toxin: Evaluation with gross motor function measure. Journal of the Formosan Medical Association 1999;98:832–836
   Google Scholar
• Galli M, Crivellini M, Santambrogio GC, Fazzi E, Motta F. Short-term effects of “botulinum toxin a” as treatment for children with cerebral palsy: Kinematic and kinetic aspects at the ankle joint. Functional Neurolology 2001;16:317–323
   PubMed Web of Science ®Google Scholar
• Love SC, Valentine JP, Blair EM, Price CJ, Cole JH, Chauvel PJ. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial. European Journal of Neurolology 2001;8:50–58
   PubMed Web of Science ®Google Scholar
• Bobath B, Bobath K. Desenvolvimento motor nos diferentes tipos de paralisia cerebral. São Paulo: Editora Manole; 1989
   Google Scholar
• Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, Andersen GL, Aydin R, Becher JG, Bernert G, et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. European Journal of Paediatric Neurology 2010;14:45–66
   PubMed Web of Science ®Google Scholar
• Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: A single-blind, randomized, controlled trial. Pediatrics 2007;119:e1149–e1158
   PubMed Web of Science ®Google Scholar
• Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Archives of Disease in Childhood 2000;83:481–487
   PubMed Web of Science ®Google Scholar
• Mall V, Heinen F, Siebel A, Bertram C, Hafkemeyer U, Wissel J, Berweck S, Haverkamp F, Nass G, Doderlein L, et al. Treatment of adductor spasticity with BTX-A in children with CP: A randomized, double-blind, placebo-controlled study. Developmental Medicine and Child Neurology 2006;48:10–13
   PubMed Web of Science ®Google Scholar
• Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, Sanders J, D'Astous J, Aiona MD; Shriners Hospitals BTXASG. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Developmental Medicine and Child Neurology 2005;47:620–627
   PubMed Web of Science ®Google Scholar
• Tedroff K, Lowing K, Haglund-Akerlind Y, Gutierrez-Farewik E, Forssberg H. Botulinum toxin A treatment in toddlers with cerebral palsy. Acta Paediatrica 2010;99:1156–1162
   PubMed Web of Science ®Google Scholar
• Williams SA, Reid S, Elliott C, Shipman P, Valentine J. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy. Developmental Medicine and Child Neurology 2013;55:813–820
   PubMed Web of Science ®Google Scholar
• Chaturvedi SK, Rai Y, Chourasia A, Goel P, Paliwal VK, Garg RK, Rathore RK, Pandey CM, Gupta RK. Comparative assessment of therapeutic response to physiotherapy with or without botulinum toxin injection using diffusion tensor tractography and clinical scores in term diplegic cerebral palsy children. Brain & Development 2013;35:647–653
   Google Scholar
• Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology 1997;39:214–223
   PubMed Web of Science ®Google Scholar
• Fehlings D, Yeung K, Teplicky R. The use of botulinum toxin in children with muscle stiffness: An update. Keeping current in Volume 1: CanChild Centre for Childhood Disability Research; 2002
   Google Scholar
• Graham HK, Aoki KR, Autti-Rämö I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait & Posture 2000;11:67–79
   PubMed Web of Science ®Google Scholar
• Lodha N, Naik SK, Coombes SA, Cauraugh JH. Force control and degree of motor impairments in chronic stroke. Clinical Neurophysiology 2010;121:1952–1961
   PubMed Web of Science ®Google Scholar
• Pavao SL, Dos Santos AN, de Oliveira AB, Rocha NA. Functionality level and its relation to postural control during sitting-to-stand movement in children with cerebral palsy. Research in Developmental Disabilities 2014;35:506–511
   PubMed Web of Science ®Google Scholar
• Park ES, Park CI, Kim DY, Kim YR. The effect of spasticity on cortical somatosensory-evoked potentials: Changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection. Archives of Physical Medicine and Rehabilitation 2002;83:1592–1596
   PubMed Web of Science ®Google Scholar
• Frascarelli F, Di Rosa G, Bisozzi E, Castelli E, Santilli V. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy. European Journal of Paediatric Neurology 2011;15:59–64
   Google Scholar